Abstract:Abstract Background As a member of the ERM (ezrin-radixin-moesin) protein family, EZR has been recognized as a regulator of adhesion signal pathways by researchers. Moreover, EZR was thought to play irreplaceable roles in invasion and metastasis of versatile cancers. In this study, we managed to undermine the effect of EZR on proliferation and metastasis in pancreatic cancer (PC). Methods To analyze the impact of EZR expression on overall survival and free diseases survival of PC patients, we screened abnormally expressed EZR in PC using the Gene Expression Omnibus database (GEO database) and The Cancer Genome Atlas (TCGA) database. Following, Gene Ontology (GO)-based functional analysis and Gene set enrichment analysis (GSEA) was performed to predicate the possible biological processes in which EZR were involved. The clinicopathological characteristics and prognosis of PC patients were analyzed according to clinical data. Further, immunohistochemistry, western blotting and real time PCR analysis were conducted to analyze the expression level of EZR in PC and paired paracancerous tissues. The effect of EZR on proliferation of PC cell lines were detected by Cell Counting Kit-8 assay, and meanwhile, Transwell assay was performed to detect the effect of EZR on invasion and migration of PC cell. Result EZR exhibited higher expression level in pancreatic cancer tissues and cell than paracancerous tissues and cell, and its expression level was positively correlated with poor overall survival and diseases-free survival in PC patients. CCK8 assay indicated that EZR facilitated the proliferation of PC cells, meanwhile, Transwell assay showed that EZR promoted the migration and invasion of PC cells. The GO analysis predicated that EZR was involved in biological processes including cell adhesion, ameboidal-type cell migration, cell junction assembly. Through GSEA analysis, pancreatic cancer pathway, and the adhesion junction pathway were screened as the mostly enriched pathways in EZR-regulated pathological process. The inhibition of EZR suppressed proliferation and migration of PC cells. Western blot experiment revealed a positive correlation between EZR and FAK, the proliferation invasion and migration ability of PC cells were significantly decreased after knockdown of EZR. Conclusion Our finding revealed EZR accelerated the progression of PC via FAK/AKT signaling pathway.

EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway

Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Ezrin T567 phosphorylation regulates migration and invasion of ectopic endometrial stromal cells by changing actin cytoskeleton

Acetylation of Ezrin Regulates Membrane-Cytoskeleton Interaction Underlying CCL18-elicited Cell Migration.

Ezrin Promotes Pancreatic Cancer Cell Proliferation and Invasion Through Activating the Akt/mTOR Pathway and Inducing YAP Translocation.

Expression and clinical significance of ezrin in non--small-cell lung cancer.

Ezrin Protein Overexpression Predicts the Poor Prognosis of Pancreatic Ductal Adenocarcinomas.

Activated K‐Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent with Cancer Stem Cell Phenotype

Ezrin Promotes Breast Cancer Progression by Modulating AKT Signals

Role of Epidermal Growth Factor in Invasion and Metastasis of Pancreatic Cancer Cells

The Expression And Phosphorylation Of Ezrin And Merlin In Human Pancreatic Cancer

Ezrin/NF-kB Activation Regulates Epithelial- Mesenchymal Transition Induced by EGF and Promotes Metastasis of Colorectal Cancer.

Ezrin expression and cell survival regulation in colorectal cancer

Pancreatic cancer‐derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP‐1 signaling pathways

ERas Regulates Cell Proliferation and Epithelial–mesenchymal Transition by Affecting Erk/Akt Signaling Pathway in Pancreatic Cancer

Ezrin As a Prognostic Indicator Regulates Colon Adenocarinoma Progression Through Glycolysis

EZH2-Mediated Microrna-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.

ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer

Ezrin Expression in Circulating Tumor Cells is a Predictor of Prostate Cancer Metastasis

Epidermal Growth Factor Promotes Invasiveness of Pancreatic Cancer Cells Through Nf-Kappa B-Mediated Proteinase Productions

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.